sb 202190 has been researched along with Leucocythaemia in 3 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirosawa, M | 1 |
| Nakahara, M | 1 |
| Otosaka, R | 1 |
| Imoto, A | 1 |
| Okazaki, T | 1 |
| Takahashi, S | 1 |
| Chen, Y | 1 |
| Zhao, Y | 1 |
| Wang, C | 1 |
| Xiao, X | 1 |
| Zhou, X | 1 |
| Xu, G | 1 |
| Jacquel, A | 1 |
| Herrant, M | 1 |
| Defamie, V | 1 |
| Belhacene, N | 1 |
| Colosetti, P | 1 |
| Marchetti, S | 1 |
| Legros, L | 1 |
| Deckert, M | 1 |
| Mari, B | 1 |
| Cassuto, JP | 1 |
| Hofman, P | 1 |
| Auberger, P | 1 |
3 other studies available for sb 202190 and Leucocythaemia
| Article | Year |
|---|---|
The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells.
Topics: Base Sequence; Cell Division; Cell Line, Tumor; DNA Primers; Enzyme Activation; Humans; Imidazoles; | 2009 |
Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Dose-Response Relationship, | 2012 |
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.
Topics: Base Sequence; Cell Differentiation; DNA Primers; DNA, Complementary; Enzyme Inhibitors; Humans; Imi | 2006 |